中国银河证券•封闭式基金一周看台

发表日期: 2008-01-28 08:49:50  来源: 银河证券
计算截止日:2008-1-25 数据来源:中国银河证券基金研究中心
序号 基金代码 基金简称 基金管理公司 简称 基金规模 (亿份) 到期日 剩余期限(年) 份额净值 (元) 收盘价 (元) 周净值涨跌幅度及排序 周价格涨跌幅度及排序 折价(-)/溢价(+)及排序 折价率 变化 剩余期限收益率及排序 剩余期限年平均收益率及排序 周换手率及排序

1 184700 鸿飞 宝盈 5 2008-04-14 0.22 3.5243 3.395 -3.99% 26 -4.82% 8 -3.67% 33 -0.84% 3.81% 33 18.52% 1 5.18% 22

2 184712 科汇 易方达 8 2008-12-13 0.88 4.8484 4.583 -3.1% 19 -4.52% 6 -5.47% 32 -1.41% 5.79% 32 6.61% 5 6.4% 10

3 184713 科翔 易方达 8 2008-12-13 0.88 5.4087 5.002 -1.94% 7 -2.57% 4 -7.52% 31 -0.6% 8.13% 31 9.29% 4 4.96% 25

4 500025 汉鼎 富国 5 2008-12-31 0.93 2.9164 2.618 -0.04% 2 0.46% 1 -10.23% 29 0.45% 11.4% 29 12.31% 3 10.81% 3

5 184706 天华 银华 25 2009-07-11 1.46 2.473 2.064 -3.6% 24 -5.49% 13 -16.54% 23 -1.67% 19.82% 23 13.18% 2 4.46% 26

6 184703 金盛 国泰 5 2009-11-30 1.85 2.9626 2.721 -2.15% 9 -1.7% 2 -8.15% 30 0.43% 8.88% 30 4.71% 9 5.28% 19

7 184705 裕泽 博时 5 2011-05-31 3.35 3.3926 2.94 -3.5% 23 -5.65% 15 -13.34% 27 -1.97% 15.39% 27 4.37% 14 5.04% 23

8 150001 瑞福进取 国投瑞银 30 2012-07-17 4.48 1.119 1.192 -4.44% 30 -10.24% 32 6.52% 34 -6.89% -6.12% 34 -1.4% 34 17.97% 1

9 150002 大成优选 大成 47 2012-08-01 4.52 1.122 1 -5.56% 34 -6.89% 23 -10.87% 28 -1.27% 12.2% 28 2.58% 30 6.78% 8

10 184688 开元 南方 20 2013-03-26 5.17 3.2456 2.775 -2.29% 10 -3.14% 5 -14.5% 26 -0.75% 16.96% 26 3.08% 26 4.02% 28

11 500001 金泰 国泰 20 2013-03-26 5.17 3.6863 2.911 -3.27% 20 -5.64% 14 -21.03% 16 -1.98% 26.63% 16 4.67% 10 5.98% 12

12 500008 兴华 华夏 20 2013-04-27 5.26 3.7332 3.126 -2.45% 11 -2.19% 3 -16.26% 24 0.23% 19.42% 24 3.43% 24 3.43% 31

13 500003 安信 华安 20 2013-06-21 5.41 3.0903 2.358 -0.99% 3 -13.94% 34 -23.7% 9 -3.79% 31.06% 9 5.13% 6 5.04% 24

14 500006 裕阳 博时 20 2013-07-24 5.50 3.6019 2.877 -4.56% 31 -9.78% 30 -20.13% 19 -4.63% 25.2% 19 4.17% 18 4.1% 27

15 184689 普惠 鹏华 20 2014-01-05 5.95 3.7037 2.795 -4.2% 27 -9.58% 29 -24.53% 5 -4.48% 32.51% 5 4.84% 7 5.25% 20

16 184690 同益 长盛 20 2014-04-07 6.20 2.9442 2.234 -2.77% 14 -6.21% 18 -24.12% 6 -2.78% 31.79% 6 4.55% 11 2.9% 34

17 500002 泰和 嘉实 20 2014-04-07 6.20 3.4575 2.9 -1.16% 4 -6.87% 22 -16.12% 25 -5.14% 19.22% 25 2.88% 28 3.82% 29

18 184691 景宏 大成 20 2014-05-03 6.27 3.3386 2.57 -4.21% 28 -9.79% 31 -23.02% 12 -4.76% 29.91% 12 4.26% 16 3.82% 30

19 500005 汉盛 富国 20 2014-05-09 6.29 3.8273 2.915 -1.79% 6 -6.12% 17 -23.84% 7 -3.52% 31.3% 7 4.42% 13 5.44% 17

20 184692 裕隆 博时 30 2014-06-14 6.39 3.5698 2.96 -3.33% 22 -6.8% 21 -17.08% 22 -3.08% 20.6% 22 2.97% 27 5.24% 21

21 500009 安顺 华安 30 2014-06-14 6.39 2.8506 2.246 -2.6% 12 -12.91% 33 -21.21% 15 -1.13% 26.92% 15 3.8% 21 6.02% 11

22 184693 普丰 鹏华 30 2014-07-13 6.47 3.058 2.3 -4.35% 29 -7.78% 25 -24.79% 4 -2.8% 32.96% 4 4.5% 12 5.72% 14

23 500018 兴和 华夏 30 2014-07-13 6.47 3.091 2.37 -3% 16 -6.55% 19 -23.33% 11 -2.92% 30.42% 11 4.19% 17 3.21% 33

24 184698 天元 南方 30 2014-08-25 6.59 3.2102 2.54 -2.71% 13 -5.22% 10 -20.88% 17 -2.1% 26.39% 17 3.62% 22 3.28% 32

25 500011 金鑫 国泰 30 2014-10-20 6.74 3.0814 2.377 -3.03% 17 -4.69% 7 -22.86% 13 -1.34% 29.63% 13 3.93% 20 9.12% 5

26 184699 同盛 长盛 30 2014-11-04 6.78 2.8553 2.18 -2.92% 15 -5.42% 12 -23.65% 10 -2.02% 30.98% 10 4.06% 19 6.79% 7

27 184701 景福 大成 30 2014-12-29 6.93 2.8516 2.122 -5.26% 33 -9.35% 28 -25.59% 2 -3.36% 34.38% 2 4.36% 15 5.49% 15

28 500015 汉兴 富国 30 2014-12-29 6.93 2.6597 1.921 -2.08% 8 -8.35% 26 -27.77% 1 -4.93% 38.45% 1 4.81% 8 11.25% 2

29 500038 通乾 融通 20 2016-08-28 8.60 3.276 2.45 -1.6% 5 -6.06% 16 -25.21% 3 -3.54% 33.71% 3 3.44% 23 6.54% 9

30 184728 鸿阳 宝盈 20 2016-12-09 8.88 2.4563 1.873 -3.66% 25 -7.05% 24 -23.75% 8 -2.78% 31.14% 8 3.1% 25 8.12% 6

31 500056 科瑞 易方达 30 2017-03-11 9.13 3.7905 3.007 -3.31% 21 -5.14% 9 -20.67% 18 -1.53% 26.06% 18 2.57% 31 5.73% 13

32 184721 丰和 嘉实 30 2017-03-21 9.16 3.1204 2.515 0% 1 -5.27% 11 -19.4% 20 -4.48% 24.07% 20 2.38% 32 5.36% 18

33 184722 久嘉 长城 20 2017-07-04 9.45 3.9307 3.201 -4.84% 32 -9.06% 27 -18.56% 21 -3.77% 22.8% 21 2.2% 33 5.45% 16

34 500058 银丰 银河 30 2017-08-14 9.56 2.211 1.709 -3.03% 18 -6.71% 20 -22.7% 14 -3.05% 29.37% 14 2.73% 29 10.68% 4
郑重声明:
本版文章内容纯属作者个人观点,并不构成投资建议,仅供投资者参考,与爱基金网无关。由于文中陈述文字并未经过证实,爱基金网不保证其内容的准确性、可靠性和有效性。如果读者据此操作,或者向发表本文的机构进行咨询并听取其操作建议,风险自担。